Trial Profile

A phase I, first-in-human, safety trial of AT-1501 in healthy volunteers and patients with Amyotrophic Lateral Sclerosis (ALS)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

16 Aug 2023 According to an Eledon Pharmaceuticals media release, company will report interim clinical data from this study at the American Society of Nephrology (ASN) Kidney Week Annual Meeting in November 2023.
05 May 2021 According to an Eledon Pharmaceuticals media release, data from this study will be presented at the virtual American Transplant Congress (ATC) meeting, June 4-9, 2021.
18 Nov 2019 According to an Anelixis Therapeutics media release, the company plans to present data from this trial at an upcoming scientific meeting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com